ITI Pharma and Healthcare Fund - Dir (G)


Sectoral / Thematic
  • NAV 17.88 (-0.99%)
  • Fund Size (Cr) ₹194.84
  • Expense Ratio 0.47
  • Scheme Type Active Fund
  • Value Research Stars
  • Minimum investment ₹5000
  • Minimum Additional Investment ₹1000
  • Minimum SIP Investment ₹500
  • Minimum Withdrawal ₹1000
  • Exit Load 1%
  • Return Since Launch 22.61%

Basic Details

Scheme Manager
Rohan Korde
Bench Mark
NIFTY Healthcare TRI
Type
OPEN

Lumpsum Returns

  • Period Invested For
  • ₹10000 Invested on
  • Latest Value
  • Absolute Returns
  • Annualised Returns
  • Category Avg
  • Rank within Category
  • 1 Week
  • 24-Sep-24
  • 10057.76
  • 0.58%
  • -
  • -0.18%
  • 163/745
  • 1 Month
  • 30-Aug-24
  • 10296.64
  • 2.97%
  • -
  • 2.54%
  • 303/741
  • 3 Month
  • 01-Jul-24
  • 12036.89
  • 20.37%
  • -
  • 8.37%
  • 21/713
  • 6 Month
  • 01-Apr-24
  • 12531.77
  • 25.32%
  • -
  • 21.57%
  • 169/668
  • 1 Year
  • 29-Sep-23
  • 15616.91
  • 56.17%
  • 56.17%
  • 46.63%
  • 137/592
  • 3 Year
  • -
  • -
  • -
  • -
  • -
  • -/-
  • 5 Year
  • -
  • -
  • -
  • -
  • -
  • -/-
  • Since Inception
  • 08-Nov-21
  • 18056.90
  • 80.57%
  • 22.61%
  • 22.98%
  • 264/753

Note: Lumpsum Returns since Inception Date.

SIP Returns

  • Period Invested For
  • ₹10000 Invested on
  • Investments
  • Latest Value
  • Absolute Returns
  • Annualised Returns
  • 1 Year
  • 03-Oct-23
  • 130000
  • 166145.42
  • 27.80%
  • 27.80%
  • 3 Year
  • -
  • -
  • -
  • -
  • -
  • 5 Year
  • -
  • -
  • -
  • -
  • -
  • 10 Year
  • -
  • -
  • -
  • -
  • -

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

  • Investment Type

  • Monthly Investment

  • Expected Returns Rate

    %
  • Time Period

    yrs

Total of your Investment will be

0

70%
Returns
  • Invested Amount

    0
  • Estimated Returns

    0
Why Wait? Start Investing
  • Select Scheme

  • Investment Type

  • Monthly Investment

  • Time Period


Total of your Investment will be

0

70%
Returns
  • Invested Amount

    0
  • Estimated Returns

    0
* The calculator shows annualized returns.
Why Wait? Start Investing

Risk Ratios

  • Standard Deviation
    4.54%
  • Beta
    0.90%
  • Sharpe Ratio
    0.98%
  • Treynor’s Ratio
    0.36%
  • Jension’s Alpha
    3.05%

Asset Allocation

There is no Asset Allocation data.

Sector Allocation

There is no Sector Allocation data.

Top 10 stock holding in portfolio

  • Stock Invested in
  • % of Total Holdings
  • Quantity
  • Value (Cr)
  • Asset Type
  • Segment
  • Sun Pharma.Inds.
  • 15.92%
  • 170322
  • 31.03
  • Equity
  • Pharmaceuticals
  • Lupin
  • 7.04%
  • 61271
  • 13.73
  • Equity
  • Pharmaceuticals
  • Apollo Hospitals
  • 5.55%
  • 15611
  • 10.81
  • Equity
  • Healthcare
  • Suven Pharma
  • 5.3%
  • 96139
  • 10.32
  • Equity
  • Pharmaceuticals
  • Cipla
  • 5.21%
  • 61283
  • 10.14
  • Equity
  • Pharmaceuticals
  • Aurobindo Pharma
  • 4.51%
  • 55951
  • 8.78
  • Equity
  • Pharmaceuticals
  • Divi's Lab.
  • 4.37%
  • 16724
  • 8.52
  • Equity
  • Pharmaceuticals
  • Dr Reddy's Labs
  • 3.99%
  • 11053
  • 7.77
  • Equity
  • Pharmaceuticals
  • Zydus Lifesci.
  • 3.75%
  • 64722
  • 7.3
  • Equity
  • Pharmaceuticals
  • Laurus Labs
  • 2.77%
  • 114874
  • 5.40
  • Equity
  • Pharmaceuticals

Peer Comparison

  • Scheme Name
  • Value Research
  • Asset Size (Cr)
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • ITI Pharma and Healthcare Fund - Dir (G)
  • Stars
  • 194.84
  • 2.97%
  • 20.37%
  • 25.32%
  • 56.17%
  • -
  • HDFC Defence Fund - Direct (G)
  • Stars
  • 3952.35
  • -3.08%
  • -8.21%
  • 29.65%
  • 83.64%
  • -
  • HDFC Defence Fund - Direct (IDCW)
  • Stars
  • 3952.35
  • -3.08%
  • -8.21%
  • 29.65%
  • 83.64%
  • -
  • LIC MF Infrastructure Fund - Direct (G)
  • Stars
  • 725.1
  • -0.39%
  • 3.66%
  • 36.63%
  • 75.79%
  • 36.15%
  • LIC MF Infrastructure Fund - Direct (IDCW)
  • Stars
  • 725.1
  • -0.39%
  • 3.66%
  • 36.61%
  • 75.69%
  • 35.97%
  • Bandhan Infrastructure Fund - Direct (G)
  • Stars
  • 1964.83
  • 0.63%
  • 2.81%
  • 28.37%
  • 74.93%
  • 35.26%

News

  • ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme ITI Mutual Fund has announced 16 August 2024 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:

    ITI Balanced Advantage Fund:

    Regular Plan ' IDCW: 0.10

    Direct Plan ' IDCW: 0.10

    Powered by Capital Market - Live News

  • ITI Mutual Fund announces change in Key Personnel ITI Mutual Fund has announced that Mr. Chintan Valia has been appointed in place of Mr. Bhuta, as an Associate Director of ITI Asset Management Limited (ITIAML) with effect from July 25, 2024. His brief profile

    Details of Mr. Chintan Valia

    Age: 41 years

    Designation: Associate Director

    Qualification: Chartered Accountant & MBA from IIM Bangalore

    Powered by Capital Market - Live News

Fund House Details & Investment Objective

  • Date of Incorporation 18-Oct-2021
  • Total AUM (Cr) ₹194.84

ITI Pharma and Healthcare Fund - Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, ITI Mutual Fund. Launched in Oct 2021, this fund is managed by Rohan Korde. With assets under management (AUM) worth ₹194.84 (Cr), as of 03-Oct-2024, ITI Pharma and Healthcare Fund - Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 22.61% since its launch.
The current NAV of ITI Pharma and Healthcare Fund - Dir (G) is ₹17.88, as on 03-Oct-2024. The fund’s benchmark index is NIFTY Healthcare TRI. You can invest in ITI Pharma and Healthcare Fund - Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units; Nil, if redeemed or switched out after completion of 12 months from the date of allotment of units.
The fund has generated - and - CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.9% in Equity and 1.1% in cash and cash equivalents
The top 5 sectors the fund invests in are: 79.22% in Pharmaceuticals & Biotech, 16.34% in Healthcare Services, 2.02% in Chemicals & Petrochemical, 1.36% in Cash & Others and 1.06% in Fertilisers & Agrochemica.

FAQs on ITI Pharma and Healthcare Fund - Dir (G)

ITI Pharma and Healthcare Fund - Dir (G) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 22.61% since inception. Looking to invest in ITI Pharma and Healthcare Fund - Dir (G)? How about earning 1% extra return? All this is possible with m.Stock! Investing in ITI Pharma and Healthcare Fund - Dir (G) is super easy and convenient with m.Stock. Here’s how you can begin:

  • Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
  • In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
  • In the search bar, enter the fund name, in this case, ITI Pharma and Healthcare Fund - Dir (G)
  • On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
  • If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
  • If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.

So, why wait? Invest in ITI Pharma and Healthcare Fund - Dir (G) today and reap the benefits of this Sectoral / Thematic fund!

In the short term, i.e., 1 year, ITI Pharma and Healthcare Fund - Dir (G) has generated annualised return of 56.17%. In the long-term, the fund has generated - and - in 3 and 5 years respectively. Since its inception, the fund has generated 22.61% returns.

The expense ratio of ITI Pharma and Healthcare Fund - Dir (G) Direct Growth is 0.47%. Expense ratio is the fees payable by investors of the scheme towards management, research and overall upkeep of the fund. The higher the expense ratio, the lower is the in-hand return for the investor. Expense ratio for direct plans is lower than regular plans, making them ideal for investors.

The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund - Dir (G) is ₹194.84 (Cr) as of 03 October 2024. AUM shows the fund’s popularity and is often indicative of fund strength.

Redeeming or selling units of ITI Pharma and Healthcare Fund - Dir (G) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.

To redeem from ITI Pharma and Healthcare Fund - Dir (G):

  • Login to your m.Stock account
  • In portfolio, your mutual fund investments will be visible under ‘MF’
  • Select the fund you wish to redeem from (in this case ITI Pharma and Healthcare Fund - Dir (G)).
  • Click on ‘Redeem’ button
  • You have 2 options – redeem by units and redeem by value (you can only redeem free units)
  • Select units to be redeemed and click on submit.
  • Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).

Yes, you can invest both lumpsum and SIP in ITI Pharma and Healthcare Fund - Dir (G). Minimum lumpsum investment ITI Pharma and Healthcare Fund - Dir (G) is ₹5000 and minimum SIP amount is ₹500. Lumpsum option is ideal for investors with higher investible corpus and market experience. SIP option is recommended for retail investors who do not have the time or expertise to time the market.

The latest NAV (Net Asset Value) of ITI Pharma and Healthcare Fund - Dir (G) is ₹17.88 as on 03 October 2024.

The 5 biggest stock holdings of ITI Pharma and Healthcare Fund - Dir (G) are:
Sun Pharma.Inds. (15.92%), Lupin (7.04%), Apollo Hospitals (5.55%), Suven Pharma (5.3%), Cipla (5.21%)

A majority of ITI Pharma and Healthcare Fund - Dir (G) 's AUM worth ₹194.84 (Cr) is invested in these 3 top sectors:

  • Pharmaceuticals & Biotech: 79.22%
  • Healthcare Services: 16.34%
  • Chemicals & Petrochemical: 2.02%

Power your investments with our smart trading platforms

mobilefooterimg
  • app_download_icon_img
    10 million+
    App downloads
  • 1_Click_icon_img
    1-Click
    Order Placement
  • higherreturns_icon_img
    2,203 Crore+
    Average Daily Turnover